Papers
Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis
BMJ 1995; 310 doi: https://doi.org/10.1136/bmj.310.6994.1571 (Published 17 June 1995) Cite this as: BMJ 1995;310:1571
Related articles
- No related articles found.
See more
- GSK settles most US lawsuits over Zantac for $2.2bnBMJ October 11, 2024, 387 q2249; DOI: https://doi.org/10.1136/bmj.q2249
- What do we know about covid-19’s effects on the gut?BMJ May 01, 2024, 385 q842; DOI: https://doi.org/10.1136/bmj.q842
- Cholera: Malawi is in grip of its deadliest outbreakBMJ February 09, 2023, 380 p328; DOI: https://doi.org/10.1136/bmj.p328
- Emergency care is in “dire” situation after loss of NHS beds, says royal collegeBMJ May 31, 2022, 377 o1376; DOI: https://doi.org/10.1136/bmj.o1376
- GP efforts to cut antibiotic use failed to curb spread of drug resistant E coli, evaluation findsBMJ August 05, 2021, 374 n1953; DOI: https://doi.org/10.1136/bmj.n1953
Cited by...
- Postnatal Ozone Exposure Disrupts Alveolar Development, Exaggerates Mucoinflammatory Responses, and Suppresses Bacterial Clearance in Developing Scnn1b-Tg+ Mice Lungs
- Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface
- Elucidating progression of early cystic fibrosis lung disease
- Progressive ventilation inhomogeneity in infants with cystic fibrosis after pulmonary infection
- Clinimetric properties of bronchoalveolar lavage inflammatory markers in cystic fibrosis
- Antibiotic and Anti-Inflammatory Therapies for Cystic Fibrosis
- Abnormal Trafficking and Degradation of TLR4 Underlie the Elevated Inflammatory Response in Cystic Fibrosis
- Randomised controlled trials in cystic fibrosis: what, when and how?
- Dysregulation of TIM-3-Galectin-9 Pathway in the Cystic Fibrosis Airways
- Bronchoalveolar lavage in children with cystic fibrosis: how many lobes should be sampled?
- Clinical Significance of Microbial Infection and Adaptation in Cystic Fibrosis
- Pseudomonas aeruginosa infection in cystic fibrosis: prevent, eradicate or both?
- Role of Excessive Inflammatory Response to Stenotrophomonas maltophilia Lung Infection in DBA/2 Mice and Implications for Cystic Fibrosis
- Respiratory medicines for children: current evidence, unlicensed use and research priorities
- Alveolar macrophages and CC chemokines are increased in children with cystic fibrosis
- Inhibition of airway proteases in cystic fibrosis lung disease
- IL-6 and IL-8 increase the expression of glycosyltransferases and sulfotransferases involved in the biosynthesis of sialylated and/or sulfated Lewisx epitopes in the human bronchial mucosa
- Exacerbations in cystic fibrosis: 3 {middle dot} Management
- Novel Neutrophil-Derived Proteins in Bronchoalveolar Lavage Fluid Indicate an Exaggerated Inflammatory Response in Pediatric Cystic Fibrosis Patients
- What and when to collect from infants with cystic fibrosis
- Exacerbations in cystic fibrosis: 2 {middle dot} Prevention
- New insights into pulmonary inflammation in cystic fibrosis.
- Upregulation of COX-1 and COX-2 in nasal polyps in cystic fibrosis
- Chronic Airway Infection/Inflammation Induces a Ca2+i-dependent Hyperinflammatory Response in Human Cystic Fibrosis Airway Epithelia
- Correlation of forced oscillation technique in preschool children with cystic fibrosis with pulmonary inflammation
- Detecting early lung disease in cystic fibrosis: are current techniques sufficient?
- Matrix metalloproteases in BAL fluid of patients with cystic fibrosis and their modulation by treatment with dornase alpha
- Early airway infection, inflammation, and lung function in cystic fibrosis
- CFTR is a pattern recognition molecule that extracts Pseudomonas aeruginosa LPS from the outer membrane into epithelial cells and activates NF-{kappa}B translocation
- Macrolide antibiotics and cystic fibrosis
- Mechanisms and markers of airway inflammation in cystic fibrosis
- Influence of neonatal screening and centralized treatment on long-term clinical outcome and survival of CF patients
- Paediatric origins of adult lung disease {bullet} 7: Cystic fibrosis
- Interlobar differences in bronchoalveolar lavage fluid from children with cystic fibrosis
- Inflammation and infection in cystic fibrosis - hen or egg?
- Intestinal inflammation in cystic fibrosis
- Treatment of Staphylococcus aureus in cystic fibrosis
- Who needs chest physiotherapy? Moving from anecdote to evidence
- The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface
- Pseudomonas aeruginosa and other related species
- Paediatric bronchoscopy
- Randomised controlled trial of inhaled corticosteroids (fluticasone propionate) in cystic fibrosis